Form 483

Wyeth Lederle SRL Form 483, 2017-04-20

FDA issued a Form 483 to Wyeth Lederle SRL on 2017-04-20 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Wyeth Lederle SRL · Catania, Italy · Issued April 20, 2017

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 Apr 2017
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Junho Pak, David J Gomes

20 Apr 2017
21 CFR 211.165(b)

Microbiological testing

Cited by Junho Pak, David J Gomes

20 Apr 2017
21 CFR 211.194(a)

Complete test data included in records

Cited by Junho Pak, David J Gomes

20 Apr 2017
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Junho Pak, David J Gomes

Inspected site

WLWyeth Lederle SRLCatania, Italy

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(b)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere